Resultats de la cerca - Bruce Robinson

Refinar resultats
  1. 1
    Benign asbestos pleural effusion: diagnosis and course.

    Benign asbestos pleural effusion: diagnosis and course. per Bruce Robinson, Arthur W. Musk

    Publicat 1981
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Natural killer cells are present in the normal human lung but are functionally impotent.

    Natural killer cells are present in the normal human lung but are functionally impotent. per Bruce Robinson, P Pinkston, Ronald G. Crystal

    Publicat 1984
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment

    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment per Delia J. Nelson, Scott Fisher, Bruce Robinson

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Risk of ESRD in the United States

    Risk of ESRD in the United States per Patrick Albertus, Hal Morgenstern, Bruce Robinson, Rajiv Saran

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. per Bruce Robinson, Theodore L. McLemore, Ronald G. Crystal

    Publicat 1985
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Authors’ Reply

    Authors’ Reply per Murilo Guedes, Bruce Robinson, Brian Bieber, Roberto Pecoits–Filho

    Publicat 2022
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  7. 7
    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all

    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all per Robbert van der Most, Andrew Currie, Bruce Robinson, Richard Lake

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Dialysis Outcomes and Practice Patterns Study (DOPPS)

    Dialysis Outcomes and Practice Patterns Study (DOPPS) per Bruce Robinson, Brian Bieber, Ronald L. Pisoni, Friedrich K. Port

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011 per Douglas S. Fuller, Ronald L. Pisoni, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. per A Venet, A J Hance, Cesare Saltini, Bruce Robinson, Ronald G. Crystal

    Publicat 1985
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression per Esdy Rozali, Stanleyson V. Hato, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Projecting ESRD Incidence and Prevalence in the United States through 2030

    Projecting ESRD Incidence and Prevalence in the United States through 2030 per Keith McCullough, Hal Morgenstern, Rajiv Saran, William H. Herman, Bruce Robinson

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011 per Ronald L. Pisoni, Douglas S. Fuller, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    The Testicular Effects of Tumor Necrosis Factor

    The Testicular Effects of Tumor Necrosis Factor per K. Mealy, Bruce Robinson, Clarke F. Millette, Joseph A. Majzoub, Douglas W. Wilmore

    Publicat 1990
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions per Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients

    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients per Bruce Robinson, Marshall M. Joffe, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives

    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives per Murilo Guedes, Bruce Robinson, Gregorio T. Obrador, Allison Tong, Ronald L. Pisoni, Roberto Pecoits–Filho

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices per Bruce Robinson, Tadao Akizawa, Kitty J. Jager, Peter G. Kerr, Rajiv Saran, Ronald L. Pisoni

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time

    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time per Bruce Robinson, Marshall M. Joffe, Jeffrey S. Berns, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice per Wayne J. Aston, Danika E. Hope, Anna K. Nowak, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: